title: The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial.
abstract: Adjuvant Nutritional Intervention in Cancer (ANICA) was a clinical study carried out in Denmark in the 1990s with 32 typical patients with breast cancer, aged 32-81 yr and classified high risk because of tumor spread to the lymph nodes. The patients received standard therapy for their breast cancer, but got from the start additionally an adjuvant therapy in form of a cocktail consisting of vitamin C (2,850 mg/day), vitamin E (2,500 IU/day), beta-carotene (32.5 IU/day), selenium (Se; 387 micrograms/day), various other vitamins and essential trace elements, essential fatty acids (1.2 g gamma-linolenic acid/day and 3.5 g omega-3 PUFAs/day), and coenzyme Q10 (CoQ10, 90 mg/day). The protocol was later changed, with reduction of the Se intake and more coenzyme Q10 than when the study was started. The average survival of high-risk breast patients in the study was 50% after 5 yr, whereas for low-risk breast cancer patients (without metastases in the axilla when treatment was started), the average survival was 90% after ten years. The main investigator died, and the final report from the ANICA study was therefore never written. However, the published preliminary results from the trial were very promising; it seems, therefore, important to follow-up this study.
authors.affiliation: a Council for Nutritional and Environmental Medicine , Mo i Rana , Norway.
authors.forename: Geir
authors.initials: G
authors.lastname: Bjørklund
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001205:Ascorbic Acid / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003718:Denmark; D005228:Fatty Acids, Essential / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D044623:Nutrition Therapy; D012643:Selenium / Q000008:administration & dosage; D015996:Survival Rate; D014131:Trace Elements / Q000008:administration & dosage; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives; D014810:Vitamin E / Q000008:administration & dosage; D014815:Vitamins / Q000008:administration & dosage; D019207:beta Carotene / Q000008:administration & dosage
chemical_list: D005228:Fatty Acids, Essential; D014131:Trace Elements; D014815:Vitamins; D019207:beta Carotene; D014451:Ubiquinone; D014810:Vitamin E; C024989:coenzyme Q10; D012643:Selenium; D001205:Ascorbic Acid